Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Ciprofloxacin Hydrochloride prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 41.4/KG in Q1 to USD 43.9/KG by Q2 as firmer fluoroquinolone synthesis intermediate costs and recovering urinary tract infection and respiratory infection formulation procurement reversed the brief Q4 2025 market correction. Globally, the average rose from USD 28.85/KG in Q1 to USD 30.58/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 30.80-34.20/KG is expected, with continued firming on Middle East supply disruptions and growing UTI treatment and broad-spectrum antibiotic sector demand globally.
Ciprofloxacin Hydrochloride is a second-generation fluoroquinolone broad-spectrum antibiotic produced by multi-step synthesis from 2,4-dichlorofluorobenzene or cyclopropylamine precursors through N-cyclopropylation, nucleophilic aromatic substitution, and quinolone ring formation steps to yield the 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid free base, converted to the monohydrochloride salt for pharmaceutical formulation. The compound exerts potent bactericidal activity through dual inhibition of bacterial DNA gyrase and topoisomerase IV enzymes, blocking DNA supercoiling and replication across a wide spectrum of Gram-negative and selected Gram-positive pathogens. The largest pull comes from urinary tract infection treatment across all severity grades, from uncomplicated cystitis to complicated pyelonephritis, where ciprofloxacin’s tissue penetration and broad spectrum support high prescribing volumes globally. Lower respiratory tract infection and community-acquired pneumonia treatment, skin and soft tissue infection management, bone and joint infection therapy, and typhoid fever treatment add further significant demand. Anthrax post-exposure prophylaxis, ophthalmic antibacterial drops for bacterial conjunctivitis, and prophylactic use in immunocompromised patients add consistent volumes. Fluoroquinolone synthesis intermediate costs, UTI prescription volumes, and regional API production capacity all feed into the price.
The balance of supply and demand for Ciprofloxacin Hydrochloride through H2 2026 leans moderately firm. Fluoroquinolone synthesis intermediate costs firmed from Middle East chemical supply disruptions. UTI treatment formulation, respiratory infection management, and broad-spectrum antibiotic access programme demand are growing with expanding healthcare coverage and antibiotic access initiatives.
The main upside risk is synthesis intermediate cost increases alongside accelerating UTI and broad-spectrum antibiotic access programme procurement. The main downside risk is Chinese API surplus and antibiotic stewardship restrictions limiting the global price recovery below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 30.80 - 34.20 | Synthesis cost firming and UTI/broad-spectrum antibiotic demand |
| United States | 33.00 - 36.40 | Steady UTI and respiratory infection demand holds firm |
| China | 22.20 - 25.60 | Large API capacity keeps it the most affordable |
| Germany | 44.40 - 47.80 | High synthesis and energy costs keep it the most expensive |
| India | 31.80 - 35.20 | Growing UTI and export demand holds a firm middle |
US Ciprofloxacin Hydrochloride prices averaged USD 35.7/KG in Q2 2026, up 5.9% from USD 33.7/KG in Q1 2026. Firmer synthesis intermediate costs and recovering UTI and respiratory infection procurement drove consistent buying through the quarter.
Why did the price of Ciprofloxacin Hydrochloride change in Q2 2026 in the United States?
Firmer fluoroquinolone synthesis intermediate costs raised the API production floor. UTI, respiratory infection, and broad-spectrum antibiotic formulation procurement lifted buying. Anthrax prophylaxis and ophthalmic antibacterial demand provided additional support near USD 35.7/KG.
Chinese Ciprofloxacin Hydrochloride prices averaged USD 24.7/KG in Q2 2026, up 6.0% from USD 23.3/KG in Q1 2026, the lowest among the tracked markets. Spring UTI and respiratory infection export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the production floor despite domestic API capacity.
Why did the price of Ciprofloxacin Hydrochloride change in Q2 2026 in China?
Spring UTI and respiratory infection export and domestic procurement lifted buying. Firmer domestic fluoroquinolone synthesis intermediate costs raised the production floor. Domestic API capacity kept China the most affordable source.
German Ciprofloxacin Hydrochloride prices averaged USD 43.9/KG in Q2 2026, up 6.0% from USD 41.4/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Consistent UTI, respiratory, and broad-spectrum antibiotic demand maintained buying.
Why did the price of Ciprofloxacin Hydrochloride change in Q2 2026 in Germany?
Higher fluoroquinolone synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis substrate chains. Consistent UTI, respiratory, and broad-spectrum antibiotic procurement maintained buying near USD 43.9/KG.
Indian Ciprofloxacin Hydrochloride prices averaged USD 33.8/KG in Q2 2026, up 6.0% from USD 31.9/KG in Q1 2026. Growing UTI and broad-spectrum antibiotic export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Ciprofloxacin Hydrochloride change in Q2 2026 in India?
Growing UTI and respiratory infection export and domestic procurement lifted buying. Firmer fluoroquinolone synthesis import costs raised the production floor. Broad-spectrum antibiotic access programme export demand provided additional support near USD 33.8/KG.
US prices averaged USD 33.7/KG in Q1 2026, recovering about 2.1% from Q4 2025. Recovering UTI and respiratory demand and firming synthesis costs held the market near USD 33.7/KG.
Why did the price of Ciprofloxacin Hydrochloride change in Q1 2026 in the United States?
Recovering UTI and respiratory infection formulation procurement maintained buying. Firming fluoroquinolone synthesis intermediate costs raised the production floor. The market recovered to USD 33.7/KG from the Q4 2025 correction.
Chinese prices averaged USD 23.3/KG in Q1 2026, recovering about 2.2% from Q4 2025. Post-Lunar New Year UTI and antibiotic export restocking and firming costs held the market near USD 23.3/KG.
Why did the price of Ciprofloxacin Hydrochloride change in Q1 2026 in China?
Post-Lunar New Year UTI and broad-spectrum antibiotic export restocking lifted buying. Firming domestic synthesis intermediate costs raised the production floor. The market recovered to USD 23.3/KG from the Q4 2025 correction.
German prices averaged USD 41.4/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering UTI and respiratory demand and firming synthesis and energy costs held the European market near USD 41.4/KG.
Why did the price of Ciprofloxacin Hydrochloride change in Q1 2026 in Germany?
Recovering UTI and respiratory antibiotic procurement maintained buying. Firming synthesis intermediate and energy costs held the production floor. The market recovered to USD 41.4/KG from the Q4 2025 correction.
Indian prices averaged USD 31.9/KG in Q1 2026, recovering about 1.9% from Q4 2025. Growing UTI and broad-spectrum antibiotic export and domestic demand and firming import costs held the market near USD 31.9/KG.
Why did the price of Ciprofloxacin Hydrochloride change in Q1 2026 in India?
Growing UTI and broad-spectrum antibiotic export and domestic procurement maintained buying. Firming synthesis import costs raised the production floor. The market recovered to USD 31.9/KG from the Q4 2025 correction.
Global Ciprofloxacin Hydrochloride prices rose in Q3 2025 on UTI and respiratory infection season procurement, dipped in Q4 2025 on synthesis cost moderation, then recovered through Q1 and Q2 2026. The average rose from USD 28.0/KG in Q2 2025 to USD 28.56/KG in Q3, eased to USD 28.28/KG in Q4, then firmed to USD 28.85/KG in Q1 2026 and USD 30.58/KG in Q2 2026, a net gain of about 9.2% over the window. Fluoroquinolone synthesis intermediate cost cycles and UTI and respiratory antibiotic procurement drove the overall pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 30.58 | +6.0% | ↑ Rising |
| Q1 2026 | 28.85 | +2.0% | ↑ Rising |
| Q4 2025 | 28.28 | -1.0% | ↓ Falling |
| Q3 2025 | 28.56 | +2.0% | ↑ Rising |
| Q2 2025 | 28.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Ciprofloxacin Hydrochloride prices firmed modestly through 2025 on consistent UTI and broad-spectrum antibiotic demand. The global average opened near USD 27.8/KG in Q1 2025 and closed at USD 28.28/KG in Q4, a full-year gain of about 1.7%. Fluoroquinolone synthesis cost dynamics and UTI and respiratory antibiotic procurement drove the quarterly pattern throughout the year.
US prices firmed from about USD 32.5/KG in Q1 2025 to USD 33.0/KG by Q4, a gain of 1.5%. Consistent UTI, respiratory, and broad-spectrum antibiotic demand maintained the modest upward trend.
Chinese prices firmed from roughly USD 22.5/KG in Q1 2025 to USD 22.8/KG by Q4, a gain of 1.3%. Growing UTI and broad-spectrum antibiotic export demand drove the firming through the year.
German prices firmed from about USD 40.0/KG in Q1 2025 to USD 40.6/KG by Q4, a gain of 1.5%. Consistent UTI, respiratory, and broad-spectrum antibiotic demand and firm synthesis costs supported.
Indian prices firmed from roughly USD 30.8/KG in Q1 2025 to USD 31.3/KG by Q4, a gain of 1.6%. Growing UTI and broad-spectrum antibiotic export and domestic demand drove modest firming.
Expert Market Research: Your Source for Real-Time Ciprofloxacin Hydrochloride Price Intelligence
Expert Market Research tracks Ciprofloxacin Hydrochloride prices continuously across every major producing and consuming region. The team traces causation through fluoroquinolone synthesis intermediate economics, UTI and broad-spectrum antibiotic procurement cycles, and regional API production capacity. Contact Expert Market Research today for Ciprofloxacin Hydrochloride pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Urinary tract infection treatment across all severity grades takes the largest share, supported by excellent tissue penetration and broad Gram-negative spectrum. Lower respiratory tract and community-acquired pneumonia treatment, skin and soft tissue infection management, bone and joint infections, typhoid fever treatment, anthrax post-exposure prophylaxis, and ophthalmic antibacterial drops also consume significant volumes globally.
The Q2 2026 average was USD 35.7/KG in the United States, USD 24.7/KG in China, USD 43.9/KG in Germany, and USD 33.8/KG in India. Germany remains the highest-priced market.
The global average rose from USD 28.85/KG in Q1 to about USD 30.58/KG in Q2, a gain of around 6.0%. Recovering UTI and respiratory infection procurement and firmer synthesis intermediate costs drove the H1 firming from the Q4 2025 correction.
Fluoroquinolone synthesis intermediate cost moderation eased the API production floor. Seasonal UTI and respiratory infection procurement moderation reduced buying urgency before the H1 2026 recovery.
The global average is expected in the USD 30.80 to 34.20/KG range for H2 2026, with continued firming as synthesis intermediate costs stay elevated and UTI treatment and broad-spectrum antibiotic sector demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on UTI and antibiotic demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to fluoroquinolone synthesis intermediate costs, UTI incidence and antibiotic prescription volume cycles, and antibiotic stewardship policy changes. Aromatic synthesis substrate prices and UTI treatment guideline updates are key signals.
China and India hold the largest ciprofloxacin hydrochloride API production capacity. Any synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time UTI formulation and broad-spectrum antibiotic contracts around synthesis cost cycles, build cover when fluoroquinolone intermediate signals tighten, and monitor UTI prescription volume data as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.